The two aforementioned adipocytic populations can delay the healing process, which is at least partially attributed to DPP4 (dipeptidyl peptidase-4), a protease acts commonly as a target of treating diabetes clinically and can be released by CD45−CD31−Sca1+CD24+ cells and APCs after adipogenic differentiation. Here, DPP4 is linked to diabetes mellitus.